Search

Home > GRACEcast Lung Cancer Video > Dr. David Spigel: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Podcast: GRACEcast Lung Cancer Video
Episode:

Dr. David Spigel: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Category: Science & Medicine
Duration: 00:02:09
Publish Date: 2013-06-21 00:30:19
Description:

Dr. David Spigel gives his view on more widespread availability of new mutation tests, provides his perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for other lung cancer subtypes.
Total Play: 0